NATCO Pharma Limited recalls Lansoprazole Delayed-Release Capsules USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.
- Products
-
- Lansoprazole Delayed-Release Capsules USP
- Company
- NATCO Pharma Limited
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 4260 bottles
- About this recall
- Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41